Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.
Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J, Loric S, Moutereau S, Sahali D, Wagner-Ballon O, Remy P, Lang P, Grimbert P, Audureau E, Godeau B, Galacteros F, Audard V. Bartolucci P, et al. Among authors: audureau e. J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19. J Am Soc Nephrol. 2016. PMID: 26586692 Free PMC article.
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study.
Villafane G, Thiriez C, Audureau E, Straczek C, Kerschen P, Cormier-Dequaire F, Van Der Gucht A, Gurruchaga JM, Quéré-Carne M, Evangelista E, Paul M, Defer G, Damier P, Remy P, Itti E, Fénelon G. Villafane G, et al. Among authors: audureau e. Eur J Neurol. 2018 Jan;25(1):120-127. doi: 10.1111/ene.13474. Epub 2017 Oct 23. Eur J Neurol. 2018. PMID: 28960663 Clinical Trial.
Moderate-intensity endurance-exercise training in patients with sickle-cell disease without severe chronic complications (EXDRE): an open-label randomised controlled trial.
Gellen B, Messonnier LA, Galactéros F, Audureau E, Merlet AN, Rupp T, Peyrot S, Martin C, Féasson L, Bartolucci P; EXDRE collaborative study group. Gellen B, et al. Among authors: audureau e. Lancet Haematol. 2018 Nov;5(11):e554-e562. doi: 10.1016/S2352-3026(18)30163-7. Lancet Haematol. 2018. PMID: 30389037 Clinical Trial.
Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study.
Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M. Attias P, et al. Among authors: audureau e. J Clin Med. 2019 Apr 30;8(5):594. doi: 10.3390/jcm8050594. J Clin Med. 2019. PMID: 31052269 Free PMC article.
Molecular testing for respiratory pathogens in sickle cell disease adult patients presenting with febrile acute chest syndrome.
Raffetin A, Melica G, Audureau E, Habibi A, Decousser JW, Fourati S, Razazi K, Lepeule R, Guillaud C, Khellaf M, Bartolucci P, Gallien S. Raffetin A, et al. Among authors: audureau e. Med Mal Infect. 2020 Feb;50(1):49-56. doi: 10.1016/j.medmal.2019.04.391. Epub 2019 May 11. Med Mal Infect. 2020. PMID: 31088757 Free PMC article.
Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.
Roumenina LT, Chadebech P, Bodivit G, Vieira-Martins P, Grunenwald A, Boudhabhay I, Poillerat V, Pakdaman S, Kiger L, Jouard A, Audureau E, Pirenne F, Galactéros F, Frémeaux-Bacchi V, Bartolucci P. Roumenina LT, et al. Among authors: audureau e. Am J Hematol. 2020 May;95(5):456-464. doi: 10.1002/ajh.25742. Epub 2020 Feb 19. Am J Hematol. 2020. PMID: 31990387 Free article.
234 results